chemokine receptor inhibitor program (ChemoCentryx)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namechemokine receptor inhibitor program (ChemoCentryx)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 1 antagonistsC-C chemokine receptor type 2 antagonistsC-C chemokine receptor type 4 antagonists +[6] 
TargetsC-C chemokine receptor type 4C-C chemokine receptor type 5C-C chemokine receptor type 2 +[6] 
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChemocentryx Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChemocentryx Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A